03 Profile
Vital Signsby Bridgehead
Hansard to 13 November 2026 · 31,544 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Women's health & gynaecology
Anuja Dokras: no photograph is held, so the academic plate is shown instead.
Academic
Anuja Dokras
MD, MHCI, PhD, professor of obstetrics and gynecology at the Hospital of the University of Pennsylvania and director of the Penn Polycystic Ovary Syndrome Center
Dec 2025Jan 2026FebMarAprMayJuneJulyAugSeptOctNovto date
2
Quoted in the press, across 2 topics since 22 Oct 2024
02 Quoted on · 1 of 29 topics
Anuja Dokras: key facts
- Kind of voice
- Academic
- Role
- MD, MHCI, PhD, professor of obstetrics and gynecology at the Hospital of the University of Pennsylvania and director of the Penn Polycystic Ovary Syndrome Center
- Quoted on
- Women's health & gynaecology
- Press coverage
- Quoted in the press
- Most recently quoted
- 20 Jul 2026
- First quoted
- 22 Oct 2024
04 The signal · where Anuja Dokras sits on women's health & gynaecology
Regularly cited
One of the voices most often quoted in the press on women's health & gynaecology.
Placed by press coverage on this topic only, not across all topics.
Dr Sue MannClinicianNational Clinical Director for Women's Health, NHS EnglandLeading
Dr Alison WrightClinicianPresident, Royal College of Obstetricians and Gynaecologists (RCOG)Leading
Prof Ranee ThakarClinicianPresident (2022–2025), Royal College of Obstetricians and Gynaecologists; Consultant Obstetrician and Urogynaecologist, Royal College of Obstetricians and Gynaecologists (RCOG)Leading- Dr Elise DallasClinicianwomen's health GP and menopause specialist at London General PracticeRegularly cited
Dr Sarah JarvisClinicianGP (locum) and Clinical Director, Patient.info; Visiting Professor of General Practice, University of Huddersfield, Patient.info (Patient Platform Limited)Regularly cited- Anuja DokrasAcademicMD, MHCI, PhD, professor of obstetrics and gynecology at the Hospital of the University of Pennsylvania and director of the Penn Polycystic Ovary Syndrome CenterRegularly cited
- Dr Gail BusbyClinicianconsultant gynaecologist at Manchester University NHS Foundation TrustRegularly cited
- Janet LindsaySector leaderChief Executive, Wellbeing of WomenRegularly cited
Showing the leading voices and those placed around Anuja Dokras · See every voice on the topic →
05 On the record · press
What Anuja Dokras has said
By outlet · bar length shows relative volume
- healio.com
- pennmedicine.org
- medpagetoday.com
- scientificamerican.com
Where Anuja Dokras has been quoted
- PMOS raises risk of heart disease | Penn Medicinepennmedicine.org · 20 Jul 2026
- You’ve been lied to about PCOS. Its new name tries to correct thatscientificamerican.com · 5 Jun 2026
- Opinion | What's in a Name? A New One Might Help PCOS Patientsmedpagetoday.com · 14 Jan 2026
- Women with PCOS on birth control do not raise certain risks | Penn Medicinepennmedicine.org · 22 Dec 2025
- PCOS with diagnosed depression may signal greater cardiometabolic riskhealio.com · 25 Mar 2025
- Common PCOS treatments do not increase, decrease metabolic syndrome riskhealio.com · 22 Oct 2024
How we found the articles that name Anuja Dokras: we searched news for these terms.
- women's health
- gynaecology
- endometriosis
- menopause
- HRT
- cervical screening
- women's health strategy
- women's health hub
Also searched with “women's health” in each of 8 national papers, and in the Guardian by editor tag. Every term for Women's health & gynaecology
Verbatim
“Our work shows that it is imperative for clinicians to closely track and evaluate cardiovascular health in patients with PMOS.”
“So this began in 2012. We had a meeting at the NIH, the National Institutes of Health. It was a multidisciplinary meeting on PCOS, as it was called then. We had made a significant amount of research progress, and we wanted to share that with the NIH, and they then produced a white paper.”
“my research and that of other world experts strongly suggest PCOS is a hormonal or endocrine disorder affecting the fat tissue, ovaries, liver, brain, and even the microbiome”
“Our results can help guide treatment decisions right away. Oral birth control remains a safe and effective first-line option for managing PCOS symptoms, and our research showed providers can prescribe it alone with greater peace of mind knowing that it's safe and effective for these higher risk patients.”
“We recognize that patients with PCOS are at increased risk for cardiometabolic risk factors — obesity, high blood pressure, prediabetes — and we have studied that in the form of metabolic syndrome. The prevalence of metabolic syndrome is high among women with PCOS in their 20s and 30s.”
“The results are reassuring that low-dose oral contraceptive pills can be used for comprehensive management of the higher-risk PCOS phenotype, as we did not observe a significant change in the prevalence of metabolic syndrome.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- HRT prescribing rose 12% last year but inequalities persistwww.thepharmacist.co.uk
- Seven in ten Obstetrics and Gynaecology trainees at risk of burnout, new data showsRoyal College of Midwives
- Longevitix launches women’s health extension to AI platformFemTech World
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.